270 related articles for article (PubMed ID: 16006182)
1. Recent applications of protein crystallography and structure-guided drug design.
Williams SP; Kuyper LF; Pearce KH
Curr Opin Chem Biol; 2005 Aug; 9(4):371-80. PubMed ID: 16006182
[TBL] [Abstract][Full Text] [Related]
2. High-throughput protein crystallography and drug discovery.
Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H
Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479
[TBL] [Abstract][Full Text] [Related]
3. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
4. High-throughput X-ray crystallography for drug discovery.
Blundell TL; Patel S
Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
[TBL] [Abstract][Full Text] [Related]
5. Structure-based development of target-specific compound libraries.
Orry AJ; Abagyan RA; Cavasotto CN
Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
[TBL] [Abstract][Full Text] [Related]
6. Crystallization to obtain protein-ligand complexes for structure-aided drug design.
Danley DE
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):569-75. PubMed ID: 16699182
[TBL] [Abstract][Full Text] [Related]
7. Structural genomics in the biotechnology sector.
Dry S; McCarthy S; Harris T
Nat Struct Biol; 2000 Nov; 7 Suppl():946-9. PubMed ID: 11103995
[TBL] [Abstract][Full Text] [Related]
8. Between a rock and a hard place?
Whitty A; Kumaravel G
Nat Chem Biol; 2006 Mar; 2(3):112-8. PubMed ID: 16484997
[TBL] [Abstract][Full Text] [Related]
9. Structure-based drug discovery and protein targets in the CNS.
Hubbard RE
Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
[TBL] [Abstract][Full Text] [Related]
10. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
11. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design.
Tsao DH; Sutherland AG; Jennings LD; Li Y; Rush TS; Alvarez JC; Ding W; Dushin EG; Dushin RG; Haney SA; Kenny CH; Malakian AK; Nilakantan R; Mosyak L
Bioorg Med Chem; 2006 Dec; 14(23):7953-61. PubMed ID: 16919463
[TBL] [Abstract][Full Text] [Related]
13. Structural proteomics in drug discovery.
Tari LW; Rosenberg M; Schryvers AB
Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
[TBL] [Abstract][Full Text] [Related]
14. Biophysical techniques for ligand screening and drug design.
Renaud JP; Delsuc MA
Curr Opin Pharmacol; 2009 Oct; 9(5):622-8. PubMed ID: 19581126
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided fragment screening for lead discovery.
Verdonk ML; Hartshorn MJ
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
[TBL] [Abstract][Full Text] [Related]
16. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
17. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
Huber W
J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based lead discovery: a chemical update.
Erlanson DA
Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
[TBL] [Abstract][Full Text] [Related]
19. Industrial perspective on X-ray data collection and analysis.
Skarzynski T; Thorpe J
Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):102-7. PubMed ID: 16369099
[TBL] [Abstract][Full Text] [Related]
20. Syrrx acquisition signals maturation of structure-based discovery.
Ratner M
Nat Biotechnol; 2005 Apr; 23(4):400. PubMed ID: 15815651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
